Green Valley Investors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $40.7M | Hold |
139,699
| – | – | 2.31% | 18 |
|
|
2019
Q2 | $41M | Sell |
139,699
-23,275
| -14% | -$6.84M | 2.33% | 18 |
|
|
2019
Q1 | $44.6M | Hold |
162,974
| – | – | 2.28% | 18 |
|
|
2018
Q4 | $36.5M | Sell |
162,974
-108
| -0.1% | -$24.2K | 2.09% | 21 |
|
|
2018
Q3 | $39.8M | Sell |
163,082
-12,737
| -7% | -$3.11M | 1.78% | 20 |
|
|
2018
Q2 | $36.4M | Sell |
175,819
-12,351
| -7% | -$2.56M | 1.71% | 23 |
|
|
2018
Q1 | $38.9M | Hold |
188,170
| – | – | 1.85% | 20 |
|
|
2017
Q4 | $35.7M | Buy |
188,170
+964
| +0.5% | +$183K | 1.7% | 21 |
|
|
2017
Q3 | $35.4M | Sell |
187,206
-22,191
| -11% | -$4.2M | 1.73% | 22 |
|
|
2017
Q2 | $36.5M | Sell |
209,397
-8,257
| -4% | -$1.44M | 1.78% | 21 |
|
|
2017
Q1 | $33.4M | Sell |
217,654
-149
| -0.1% | -$22.9K | 1.65% | 21 |
|
|
2016
Q4 | $30.7M | Sell |
217,803
-8,377
| -4% | -$1.18M | 1.61% | 21 |
|
|
2016
Q3 | $36M | Sell |
226,180
-271,275
| -55% | -$43.1M | 1.84% | 20 |
|
|
2016
Q2 | $73.5M | Sell |
497,455
-392,876
| -44% | -$58.1M | 2.25% | 17 |
|
|
2016
Q1 | $126M | Sell |
890,331
-309,669
| -26% | -$43.8M | 3.08% | 13 |
|
|
2015
Q4 | $170M | Hold |
1,200,000
| – | – | 3.49% | 11 |
|
|
2015
Q3 | $147M | Hold |
1,200,000
| – | – | 3.15% | 12 |
|
|
2015
Q2 | $156M | Hold |
1,200,000
| – | – | 3% | 14 |
|
|
2015
Q1 | $161M | Hold |
1,200,000
| – | – | 3.24% | 14 |
|
|
2014
Q4 | $150M | Hold |
1,200,000
| – | – | 3.17% | 14 |
|
|
2014
Q3 | $146M | Hold |
1,200,000
| – | – | 3.34% | 12 |
|
|
2014
Q2 | $142M | Sell |
1,200,000
-249,108
| -17% | -$29.4M | 3.29% | 13 |
|
|
2014
Q1 | $174M | Sell |
1,449,108
-250,892
| -15% | -$30.2M | 4% | 9 |
|
|
2013
Q4 | $189M | Sell |
1,700,000
-300,000
| -15% | -$33.4M | 4.13% | 7 |
|
|
2013
Q3 | $184M | Sell |
2,000,000
-700,000
| -26% | -$64.5M | 4.53% | 6 |
|
|
2013
Q2 | $229M | Buy |
+2,700,000
| New | +$229M | 5.58% | 4 |
|